Ferdinando Loiacono

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure

Claudia Marini, Gabriele Fragasso, Leonardo Italia et al. · Heart · 2020 · 86 citations

Medicine, Cardiology, Clinical Sciences +12

Guideline-Directed Medical Therapy in Severe Heart Failure with Reduced Ejection Fraction: An Analysis from the HELP-HF Registry

Daniela Tomasoni, Matteo Pagnesi, Giada Colombo et al. · European Journal of Heart Failure · 2023 · 52 citations · Full text

Medicine, Cardiology, Internal Medicine +10

The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study

Matteo Cameli, Carlotta Sciaccaluga, Ferdinando Loiacono et al. · International Journal of Cardiology · 2019 · 45 citations

Medicine, Cardiology, Physiology +13

Prognostic impact of the updated 2018 <scp>HFA‐ESC</scp> definition of advanced heart failure: results from the <scp>HELP‐HF</scp> registry

Matteo Pagnesi, Carlo Lombardi, Mauro Chiarito et al. · European Journal of Heart Failure · 2022 · 44 citations · Full text

Medicine, Cardiology, Internal Medicine +8